Cerclage with Low-Lying Placenta or Placenta Previa
Cerclage can be performed in patients with low-lying placenta or placenta previa, but the evidence shows it does not improve outcomes and is not recommended as standard practice.
Key Clinical Considerations
The question of cerclage placement in the setting of placenta previa or low-lying placenta must be separated from the standard indications for cerclage (cervical insufficiency or short cervix). The available evidence specifically addresses this clinical scenario:
Evidence Against Routine Use
The highest quality randomized controlled trial directly addressing this question found no benefit to cervical cerclage in placenta previa 1. This 1998 RCT randomized 39 women with placenta previa at 24-30 weeks to cerclage versus conservative management and found:
- No difference in gestational age at delivery
- No difference in prolongation of pregnancy
- No difference in bleeding episodes after randomization
- No difference in blood transfusion requirements
- No difference in birth weight or neonatal outcomes
A Cochrane systematic review similarly concluded there is insufficient evidence to recommend cerclage for placenta previa, though it noted one lower-quality trial suggested possible reduction in delivery before 34 weeks 2.
Limited Supportive Data
Two small case series from the 1990s reported potential benefits 3, but these were uncontrolled observational studies with significant methodological limitations. One series of only 6 patients reported mean pregnancy prolongation of 8.2 weeks, but without a comparison group, this cannot be interpreted as evidence of efficacy.
Clinical Algorithm
When encountering a patient with both short cervix AND placenta previa/low-lying placenta:
First, determine the primary indication:
- Is cervical shortening the primary concern? → Follow standard short cervix guidelines (vaginal progesterone preferred) 4
- Is placenta previa the primary concern? → Cerclage is not indicated
For short cervix without prior preterm birth: The 2024 SMFM guidelines explicitly recommend against cerclage placement in the absence of cervical dilation (GRADE 1B) 4
For placenta previa/low-lying placenta: Manage conservatively with:
- Serial ultrasound monitoring for resolution
- Pelvic rest considerations (though evidence for benefit is limited)
- Delivery planning based on placental location at term
Important Caveats
Bleeding risk considerations: Women with placenta previa have substantially increased preterm birth risk (46% before 37 weeks, 17% before 34 weeks) 5. However, cerclage placement itself carries theoretical risks in this population:
- Potential for precipitating bleeding during placement
- Mechanical trauma to low-lying placental tissue
- No demonstrated benefit in preventing preterm birth related to placenta previa
Resolution patterns: Most low-lying placentas resolve by 28 weeks (75% resolution rate), while true placenta previa resolves in only 51% of cases 6, 7. This natural history should inform timing of any intervention discussions.
Alternative interventions: The systematic review by 5 suggests that intramuscular progesterone, progesterone plus cerclage, or pessary might prolong pregnancy in placenta previa, but the data are inconsistent and insufficient to make firm recommendations.
Bottom Line
Do not place cerclage solely because of placenta previa or low-lying placenta. The only RCT showed no benefit, and the theoretical risks of bleeding during placement in the setting of abnormal placentation outweigh any unproven benefits. If cervical insufficiency is independently indicated (history-indicated cerclage), the presence of placenta previa should prompt careful consideration of risks versus benefits on a case-by-case basis, but this is not addressed in current guidelines.